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Background: Foot-and-mouth disease virus (FMDV) exhibits a high degree of antigenic variability. Studies of the
antigenic diversity and determination of amino acid changes involved in this diversity are important to the design
of broadly protective new vaccines. Although extensive studies have been carried out to explore the molecular
basis of the antigenic variation of serotype O and serotype A FMDV, there are few reports on Asia1 serotype FMDV.
Methods: Two serotype Asia1 viruses, Asia1/YS/CHA/05 and Asia1/1/YZ/CHA/06, which show differential reactivity
to the neutralizing monoclonal antibody (nMAb) 1B4, were subjected to sequence comparison. Then a reverse
genetics system was used to generate mutant versions of Asia1/YS/CHA/05 followed by comparative analysis of the
antigenicity, growth property and pathogenicity in the suckling mice.
Results: Three amino acid differences were observed when the structural protein coding sequences of Asia1/1/YZ/
CHA/06 were compared to that of Asia1/YS/CHA/05. Site-directed mutagenesis and Immunofluorescence analysis
showed that the amino acid substitution in the B-C loop of the VP2 protein at position 72 is responsible for the
antigenic difference between the two Asia1 FMDV strains. Furthermore, alignment of the amino acid sequences of
VP2 proteins from serotype Asia1 FMDV strains deposited in GenBank revealed that most of the serotype Asia1
FMDV strains contain an Asn residue at position 72 of VP2. Therefore, we constructed a mutant virus carrying an
Asp-to-Asn substitution at position 72 and named it rD72N. Our analysis shows that the Asp-to-Asn substitution
inhibited the ability of the rD72N virus to react with the MAb 1B4 in immunofluorescence and neutralization assays.
In addition, this substitution decreased the growth rate of the virus in BHK-21 cells and decreased the virulence of
the virus in suckling mice compared with the Asia1/YS/CHA/05 parental strain.
Conclusions: These results suggest that variations in domains other than the hyper variable VP1 G-H loop (amino
acid 140 to 160) are relevant to the antigenic diversity of FMDV. In addition, amino acid substitutions in the VP2
influenced replicative ability and virulence of the virus. Thus, special consideration should be given to the VP2
protein in research on structure-function relationships and in the development of an FMDV vaccine.
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Foot-and-mouth disease (FMD) is a highly infectious
and economically important disease of cloven-hoofed
animals. The causative agent, foot-and-mouth disease
virus (FMDV), is a small, non-enveloped virus that
belongs to the Aphthovirus genus of the Picornaviridae
family [1]. Like other picornaviruses, FMDV possesses a
single-stranded positive-sense RNA genome of approxi-
mately 8,500 nucleotides that are encapsidated in an
icosahedral capsid made of 60 copies each of four pro-
teins: VP1, VP2, VP3 and VP4. Seven serotypes (A, O, C,
Asia1, and South African Territories 1, 2, and 3) have
been identified serologically, and multiple subtypes
occur within each serotype [2]. The virus presents tre-
mendous antigenic variability, which has been exten-
sively characterized in the field [3-5].
Although major antigenic sites have been described in
VP1 (residues 140 to 160 and the C terminus) [5-7],
the use of monoclonal antibodies (MAb) to select
neutralization-resistant mutant viruses has demon-
strated the presence of other neutralization and non-
neutralizable sites in other proteins of the virus particle
[5,7-9]. In FMDV serotypes O, A and C, antigenic sites
in VP2 were shown to be immunologically important
[10-12], and mutations within these sites were able to
affect antigenicity of these viruses. In addition, crystal-
lographic data [13] and studies utilizing neutralization-
resistant variants have shown that amino acids 70-80 of
the VP2 B-C loop are located in close proximity to the
VP1 G-H loop [14]. Indeed, at least one epitope in the
VP2 B-C loop has been described for serotype Asia1
FMDV [4].
Serotype Asia1 FMDV has circulated widely in Asia
after first being detected in samples collected in India be-
tween 1951 and 1952 and in Pakistan in 1954 [15]. In
China, serotype Asia1 FMDV was first found in the Yun-
nan province in 1958 [16], and, at that time, this type of
FMDV was confined to the YNBS lineage. In 2005,
Jiangsu lineage serotype Asia1 FMDV Asia1/JS/CHA/05
[GenBank: EF149009], which was first isolated in India
(Asia1/IND/18/80) [GenBank: DQ121116] (Asia1/IND/
15/81) [GenBank: DQ121117], caused outbreaks in cattle
in more than 15 areas of China and resulted in severe
economic losses [17,18]. Interestingly, this serotype was
subsequently isolated from pigs in 2006 [GenBank:
FJ906802]. However, this viral lineage is poorly transmit-
ted between pigs by the classical respiratory and digestive
pathways, and it causes limited death in pigs. The present
study examined two isolates: Asia1/YS/CHA/05, which
was isolated from cows, and Asia1/1/YZ/CHA/06, which
was isolated from pigs. These isolates showed different
reactivity to the serotype Asia1 FMDV-specific monoclo-
nal antibody 1B4. The Asia1/YS/CHA/05 virus reacted
with MAb 1B4 in an indirect immunofluorescence assay(IFA) and a virus neutralization test (VNT), but the
Asia1/1/YZ/CHA/06 virus did not react with MAb 1B4.
We investigated the molecular basis for the differential
reactivity of these two viruses against MAb 1B4 using a
reverse genetics system. Our results demonstrate that a
single amino acid variation at position 72 of the VP2 pro-
tein confers the antigenic difference between these two
Asia1 FMDV isolates. Moreover, this amino acid substi-
tution at position 72 in the B–C loop of VP2 affects the
replicative ability and virulence of the virus.
Results
Production of MAb against Asia1/YS/CHA/05
Mouse spleen cells immunized with the inactivated
Asia1/YS/CHA/05 FMDV were fused with SP2/0 mye-
loma cells to generate MAb 1B4. Isotope determination
exhibited that MAb 1B4 was of the IgG1/κ-type. Virus
micro-neutralization tests (VNT) showed that MAb
1B4 neutralized the Asia1/YS/CHA/05 virus with a
neutralization titer of 1:64. However, MAb 1B4 failed to
recognize the denatured FMDV protein in a western
blot (data not shown), which suggests that the epitope
recognized by MAb 1B4 is conformation dependent.
Virus originating in pigs react weakly with MAb 1B4 in an
immunofluorescence assay
Asia1/YS/CHA/05 was isolated from cattle during an
important epizootic wave in China in 2005, and Asia1/
1/YZ/CHA/06 was isolated from pigs in 2006. We per-
formed an indirect immunofluorescence assay to test
the reactivity of MAb 1B4 against these two FMDV
strains. The results show that MAb 1B4 reacted very
weakly with the Asia1/1/YZ/CHA/06 strain from pigs
(Figure 1A), but it had strong reactivity against the
Asia1/YS/CHA/05 strain from cows (Figure 1B).
Sequence analysis of the capsid of Asia1/1/YZ/CHA/06
from pigs
In light of the significantly altered antigenic properties
of Asia1/1/YZ/CHA/06 to MAb 1B4, we sequenced the
structural protein-coding region of Asia1/1/YZ/CHA/06
to determine whether the antigenic alteration could be
ascribed to sequence variation. Compared with Asia1/
YS/CHA/05, three amino acid substitutions were found
in the P1 coding region of Asia1/1/YZ/CHA/06, includ-
ing a Ser-to-Asn substitution at position 154 (S154N) in
VP1, an Asp-to-Gly substitution at position 72 (D72G)
in VP2 and a Val-to-Ile substitution at position 107
(V107I) in VP2. Table 1 shows the amino acid substitu-
tions that were different between the two viruses.
To investigate the origin of the mutated amino acid
residues in the VP2 coding region of the porcine Asia1/
1/YZ/CHA/06 virus, we aligned the Asia1 FMDV VP2
coding regions available in GenBank. Our results showed
Figure 1 Reactivity of Asia1/YS/CHA/05 and Asia1/1/YZ/CHA/06 with MAb 1B4 in an indirect immunofluorescence assay. (A) Asia1/1/YZ/
CHA/06-infected BHK-21 cells, (B) Asia1/YS/CHA/05-infected BHK-21 cells and (C) normal BHK-21 cells as a negative control.
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of VP2 (Figure 2). In addition, the majority of Asia1
FMDV strains contain an Asn residue. Six strains
(i.e., Asia1/YS/CHA/05, Asia1/JS/CHA/05 [GenBank:
EF149009], Asia1/MOG/05 [GenBank: EF614458],
Asia1/IND/37/02 [GenBank: DQ989311], Asia1/Nepal/
29/97 [GenBank: EF134952] and Asia1/3/kimron/iso61
[GenBank: AY593797] had an Asp residue at position 72
of the VP2 protein. Importantly, Asia1/WHN/CHA/06
[GenBank: FJ906802], which is another virus that origi-
nated in pigs, also contains a Gly substitution at the
same position as Asia1/1/YZ/CHA/06. These data show
that the Asn residue at position 72 of VP2 is highly con-
served among most Asia1 FMDV strains. However, Asn
was replaced by Asp at position 72 of VP2 in the virus
originating from the Indian 1980/1981 epidemics and
the outbreaks in the cattle populations of China in 2005.
In addition, Asn was replaced by Gly in the outbreak in
pigs in 2006.
Rescue of the site-directed mutants of Asia1/YS/CHA/05
Comparative analysis of the deduced amino acid
sequences in Asia1/YS/CHA/05 and Asia1/1/YZ/CHA/
06 shows that there were three amino acid substitutions
in the P1 coding region of Asia1/YS/CHA/05 (Table 1).
Thus, it was reasonable to assume that one of these sub-
stitutions contributed to the antigenic difference be-
tween these two viruses. To verify this assumption, we
used an infectious clone of Asia1/YS/CHA/05 [6] as a
backbone to generate three plasmids containing each of
the mutations S154N, D72G and V107I described above.
In addition, because most Asia1 FMDV isolates containTable 1 Differences in amino acid residues in the P1
region between the porcine Asia1/1/YZ/CHA/06 FMDV
and the bovine Asia1/YS/CHA/05 FMDV
Strain Host Amino acid substitution
VP1/154 VP2/72 VP2/107
Asia1/YS/CHA/05 bovine Ser Asp Val
Asia1/1/YZ/CHA/06 pig Asn Gly Ilean Asn residue at position 72 of VP2, we also con-
structed a mutated pAsi plasmid with an Asp-to-Asn
substitution at the same position of VP2. Infectious
viruses were produced from these mutated cDNAs by
in vitro transcription followed by transfection of BHK-21
cells. Viruses derived from the mutated plasmids were
named rS154N, rD72G, rV107I and rD72N. The entire
sequence of the four mutant viruses were determined by
RT-PCR and sequencing, and no additional nucleotide
changes were observed in cDNAs of the four mutant
viruses. The antigenicity of the four mutant viruses was
subsequently tested with an indirect immunofluores-
cence assay using the serotype-independent MAb 4B2.
The results show that all four mutant viruses can specif-
ically react with MAb 4B2 at the same level as the
Asia1/YS/CHA/05 parental virus (Figure 3), which pro-
vides more evidence that the mutant viruses were
rescued.Asp72 is a crucial residue of the 1B4 epitope in VP2
To assess the impact of the amino acid changes on
the antigenicity of the Asia1/YS/CHA/05 parental
virus, the reactivates of the four site-directed mutant
viruses were tested against MAb 1B4 using an indir-
ect immunofluorescence assay. Our results show that
two of the mutant viruses, rS154N and rV107I,
reacted equally well with MAb 1B4 as the Asia1/YS/
CHA/05 parental virus (Figure 4A and Figure 4D),
whereas the rD72G mutant virus reacted poorly with
this MAb (Figure 4B), and the rD72N mutant virus
did not react with MAb 1B4 (Figure 4C). These
results demonstrate that an Asp residue at position
72 of the VP2 protein is crucial for recognition of the
MAb 1B4 epitope. The isolate Asia1/1/YZ/CHA/06
from pigs with an Asp-to-Gly substitution at this pos-
ition showed minor reactivity with MAb 1B4. How-
ever, the S154N substitution in VP1 and the V107I
substitution in VP2 had no effect on the epitope
recognized by 1B4, indicating that these residues were
not related to the epitope recognized by MAb 1B4.
Figure 2 Comparison of the VP2 amino acid sequence between Asia1 FMDV strains. The amino acids at position 72 are boxed.
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neutralization by 1B4
We performed virus neutralization tests to detect the
effects of site-directed mutations on the neutralizing abil-
ity of MAb 1B4. The Asia1/YS/CHA/05 and Asia1/1/YZ/Figure 3 Reactivity of the mutant viruses with MAb 4B2 by indirect im
infected BHK-21 cells, (C) rD72N-infected BHK-21 cells, (D) rV107I-infected B
control and (F) normal BHK-21 cells as a negative control.CHA/06 parental viruses were used as controls. The
results showed that the Asia1/YS/CHA/05 could be neu-
tralized by MAb 1B4 with a neutralization titer of 1:64,
but the porcine Asia1/1/YZ/CHA/06 strain completely
escaped neutralization by 1B4. For the mutant viruses, themunofluorescence. (A) rS154N-infected BHK-21 cells, (B) rD72G-
HK-21 cells, (E) Asia1/YS/CHA/05-infected BHK-21 cells as a positive
Figure 4 Reactivity of mutant viruses with MAb 1B4 by indirect immunofluorescence. (A) rS154N-infected BHK-21 cells, (B) rD72G-infected
BHK-21 cells, (C) rD72N-infected BHK-21 cells, (D) rV107I-infected BHK-21 cells, (E) Asia1/YS/CHA/05-infected BHK-21 cells as a positive control and
(F) normal BHK-21 cells as a negative control.
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izing ability of MAb 1B4, whereas the rD72G and rD72N
mutants completely escaped neutralization by the 1B4.
These results were in agreement with those of the im-
munofluorescence assay (Figure 4), which further supports
the notion that Asp72 is a crucial residue in the VP2 epi-
tope neutralized by 1B4. Indeed, the viral epitope that
could be neutralized by 1B4 disappeared when the Asp72
residue was substituted with Gly or Asn. These results
showed that a single amino acid substitution in VP2 of
Asia1 FMDV can have a dramatic effect on the neutraliz-
ing activity of the MAb 1B4.
Replicative ability of the Asp72-mutant viruses
We constructed single-step growth curves of virus pro-
duction in BHK-21 cells to test whether the amino acidFigure 5 Growth kinetics of rD72G and rD72N mutant viruses. BHK-21
(A) Single-step growth curves obtained by titration of virus present at each
shown in the graphic. (B) RNA production curves were obtained by real tim
load generated by real time RT-PCR is expressed as log10 vRNA copies/ml o
standard deviations are shown in the graphic. (◆) FMDV Asia1/YS/CHA/05,(substitutions at position 72 of VP2 influenced the ability
of the viruses to replicate in cell culture. Viral titers
recovered at different times post infection were com-
pared with those obtained with the parental Asia1/YS/
CHA/05 (Figure 5A). In the cells infected with the par-
ental virus and the rD72G mutant virus, viral titers
increased by 4 hpi, reaching a maximum titer of ap-
proximately 107 TCID50/mL at 6 hpi. After reaching this
peak, titers gradually declined to 105 TCID50/mL by the
final sample collection time at 14 hpi. Although product-
ive viral replication also occurred in rD72N-infected
cells, viral titers were lower than those of parental virus
and the rD72G mutant virus (Figure 5A). The trends in
the viral growth curves were similar to those observed
in nucleic acid copy numbers quantified by real-time
RT-PCR (Figure 5B). BHK-21 cells infected with thecells were infected and harvested at different times post infection.
time. Samples were taken in triplicates and standard deviations are
e RT-PCR assay from Trizol resuspended monolayers. The mean viral
f virus transport medium. Samples were taken in triplicates and
■) rD72G and (▲) rD72N.
Xue et al. Virology Journal 2012, 9:191 Page 6 of 10
http://www.virologyj.com/content/9/1/191parental virus and the rD72G mutant virus had increased
viral nucleic acid copy numbers from 4 hpi, reaching a
maximum after 8 hpi. In contrast, viral nucleic acid copy
numbers in the cells infected with the rD72N remained
low throughout the time course of the experiment. These
data confirmed that the rD72N mutant virus replicates to
lower titers in BHK-21 cells than does the parental virus
and the rD72G mutant virus. These results showed that
the Asp-to-Asn substitution at position 72 affected the
replicative ability of the Asia1/YS/CHA/05 virus.
Mutant virus rD72N is less virulent in suckling mice
To determine whether the substitutions in VP2 were
related to virulence in vivo, 10-fold series dilutions of
the rD72G and rD72N mutant viruses and the Asia1/
YS/CHA/05 parental strain were inoculated into 3-day-
old BALB/c suckling mice for evaluation of the 50% le-
thal dose (LD50). The results showed that the rD72G
mutant virus induced disease in suckling mice with simi-
lar severity as the parent strain, and both viruses had
similar LD50 titers (1.4 × 10
-8 and 1.5 × 10-8, respectively).
The rD72N mutant virus, however, was 10-fold less viru-
lent in suckling mice, and the LD50 titer was 1.2 × 10
-7.
The experiment was repeated for three times, and the
results were very consistent upon repeated experiments.
These results indicated that an Asp-to-Asn, but not an
Asp-to-Gly, substitution at position 72 of VP2 had an ef-
fect on virulence in mice. This was consistent with the
in vitro replication ability of these mutant viruses in
BHK-21 cells, suggesting that there is a link between
growth characteristics and in vivo virulence.
Discussion
Due to the error-prone nature of FMDV0s RNA-
dependent RNA polymerase and high replication rate
in vivo, FMDV exhibits a high degree of antigenic vari-
ability [19,20]. Studies of the antigenic diversity and de-
termination of amino acid changes involved in this
diversity are important to the design of broadly protect-
ive new vaccines [7]. Although extensive studies have
been carried out to examine the epitopes in the viral
capsids of serotype O [8,10,21] and serotype A FMDV
[11,22,23], there are few reports on Asia1 serotype
FMDV [24]. In this study, we explored the molecular
basis of the antigenic difference between two viruses,
Asia1/YS/CHA/05 from cows and Asia1/1/YZ/CHA/06
from pigs, which react differently against MAb 1B4. We
detected three amino acid substitutions in the P1 coding
region of Asia1/YS/CHA/05 by sequencing and align-
ment of these two viruses, including a Ser-to-Asn substi-
tution at position 154 (S154N) in VP1, an Asp-to-Gly
substitution at position 72 (D72G) in VP2 and a Val-to-
Ile substitution at position 107 (V107I) in VP2 (Table 1).
We expected that the S154N substitution in the VP1 G-Hloop would be related to the variation in 1B4 recognition;
however, single amino-acid substitutions based on an
FMDV reverse genetics system revealed that the D72G
substitution in VP2 contributed to this antigenic vari-
ation. Moreover, we found that the virus containing an
Asp-to-Asn substitution (D72N) had a reduced ability to
replicate in BHK-21 cells and was 10-fold less virulent in
suckling mice. These results provide evidence that amino
acid substitutions in the VP2 B-C loop of serotype Asia1
FMDV not only mediate significant antigenic diversity in
the field but also alter the replicative ability and patho-
genicity of the virus.
X-ray crystallographic data have shown that the B-C
loop of VP2 lies in the vicinity of the G-H loop of VP1
[25]. In addition, amino acid changes in the B-C loop of
VP2 in type O [10] and type A [11,23] FMDV have been
shown to contribute to an immunodominant site in
VP1. In this study, an Asp-to-Gly substitution or an
Asp-to-Asn substitution at position 72, which comprises
part of the B-C loop of VP2, inhibited the ability of the
Asia1 FMDV strain to react with MAb 1B4. Thus, the
Asp-to-Gly or Asp-to-Asn substitutions at position 72 of
VP2 may affect the conformation and/or orientation of
the VP1 G-H loop, which could impact the ability of
MAb 1B4 to recognize its epitope.
Interestingly, two closely related viruses from type
A22, which showed different behavior in cell attach-
ment assays and had different host range properties,
did not have any differences in the VP1 coding re-
gion; however, they did have three amino acid substi-
tutions in VP2. One of these substitutions (Glu82 to
Gly) on the surface of VP2 perturbed the structure of
the VP1 G-H loop, which determined the cell-binding
properties of the variants [26]. This report adds sup-
port to the idea that VP2 is important for the cell
tropism of the virus. The natural hosts of most sero-
type Asia1 FMDV strains are cattle, and there is only
one report of pigs infected with Asia1 serotype
FMDV (i.e., IND17/91 [GenBank: AF390682]). Here,
the Asia1/1/YZ/CHA/06 virus from pigs and ano-
ther porcine isolate, Asia1/WHN/CHA/06 [GenBank:
FJ906802], shared the same Asp-to-Gly substitution at
position 72 of VP2. The loss of the aspartic acid side
chain on the surface of VP2 in the porcine variants
of Asia1 FMDV may perturb the G-H loop of VP1.
Because a key determinant of the cellular tropism of
FMDV is also located in the G-H loop of VP1
[27,28], we cannot exclude that the Asp-to-Gly substi-
tution changed the host tropism of viral isolates from
a similar lineage, which may explain the difference in
host tropism of Asia1/YS/CHA/05 and Asia1/1/YZ/
CHA/06. Further investigations are needed to eluci-
date the effects of these amino acid changes on
FMDV infection of various species.
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Asia1/YS/CHA/05 in BHK-21 cells. The results of
in vitro growth analysis were consistent with those of
in vivo virulence experiments, which suggest that the
decreased growth activity of the virus caused by the
D72N mutation may contribute to the decreased viru-
lence of the rD72N mutant. A single Asp-to-Asn substi-
tution at position 72 of VP2 may influence the structure
of the virus capsid, which would account for the low
replication ability and reduced virulence of the virus.
Further studies are needed to clarify the mechanisms of
these changes.Conclusions
In summary, we explored the molecular basis of differ-
ential reactivity of two closely related Asia1 serotype
FMDV strains to MAb 1B4 by site-directed mutagenesis
using a reverse genetics system. We found that a single
amino acid substitution at position 72 in the B-C loop of
VP2 resulted in variation in the epitope recognized by
MAb 1B4 and escape from 1B4-mediated neutralization.
Our results suggest that variations in domains other
than the hyper variable VP1 G-H loop (amino acid 140
to 160) are relevant to the antigenic diversity of FMDV.
In addition, amino acid substitutions in VP2 influenced
the replicative ability and virulence of the virus. Thus,
special consideration should be given to the VP2 protein
in research on structure-function relationships and in
the development of an FMDV vaccine.Materials and methods
Ethics statement
Care of laboratory animals and animal experimentation
were performed in accordance with animal ethics
guidelines and approved protocols. All animal studies
were approved by the Animal Ethics Committee of
Harbin Veterinary Research Institute and by the Animal
Ethics Committee of Heilongjiang Province (SYXK (H)
2006-032).Viruses, cells and plasmids
The Asia1/YS/CHA/05 FMDV isolate [GenBank:
GU931682] was isolated during the pandemic in China
in 2005 [17,29], and the Asia1/1/YZ/CHA/06 FMDV
isolate [GenBank: HQ631363] was isolated from enzo-
otic of pigs in 2006 [GenBank: FJ906802]. The baby
hamster kidney cell line BHK-21 was maintained in
Dulbecco0s modified Eagle0s medium supplemented with
10% fetal calf serum (Gibco-BRL, Grand Island, NY,
USA). Viruses were propagated in BHK-21 cells. Plasmid
pAsi, an infectious clone of Asia1/YS/CHA/05 FMDV,
has been previously described [30].Monoclonal antibodies
Six-week-old female BALB/c mice were subcutaneously
immunized with 100 μg of the inactivated and purified
Asia1/YS/CHA/05 FMDV antigen emulsified in an equal
volume of adjuvant VG206 (SEPTIC, France). Two boos-
ters of the adjuvant-emulsified antigen were given at 2-
week intervals. Two weeks after the third immunization,
the mice were intraperitoneally boosted with 100 μg of
antigen without adjuvant. Three days later, spleen cells
were collected to fuse with SP2/0 myeloma cells using
50% (wt/vol) polyethylene glycol and 10% dimethyl sulf-
oxide (DMSO) (vol/vol) (Sigma, St. Louis, MO, USA).
Hybridomas were screened by an enzyme-linked im-
munosorbent assay (ELISA) and verified by an indirect
immunofluorescence assay (IFA) and a western blot. The
MAb-producing hybridoma was cloned three times by
limiting dilution of the cells. Antibody subtype identifi-
cation was performed using the SBA ClonotypingTM
System/HRP Kit (Southern Biotech, Birmingham, AL,
USA). The FMDV serotype-independent MAb 4B2 has
been previously described [31].
Site-directed mutagenesis and construction of
recombinant plasmids
Plasmid pPM was generated by digesting plasmid pAsi
with PstI and MluI to generate a fragment containing
the VP1 gene. This fragment was ligated with plasmid
pOK12, which had previously been digested with PstI
and MluI. Plasmid pNP was generated by digesting pAsi
with NdeI and PstI to generate a fragment containing
the VP2 gene. This fragment was ligated with pOK12,
which had previously been digested with NdeI and PstI.
The plasmid pPM and pNP were used as templates for
site-directed mutagenesis and the amplified DNA were
digested with restriction enzyme DpnI according to the
reference previously reported with minor modifications
[32]. The primers used to introduce the specific muta-
tion shown in Table 2. For PCR, the 50 μL reaction mix-
ture was comprised of 10 μL of 5 × Prime STAR buffer, 4
μL of 2.5 mM deoxy ribonucleotide triphosphates
(dNTP), 2 μL of forward primer, 2 μL of reverse primer,
1 μL of Prime STAR HS DNA polymerase, 30.5 μL of
sterile ddH2O and 0.5 μL of pPM or pNP. The PCR
protocol consisted of 4 min of pre-denaturation at 94°C;
18 cycles of 94°C for 1 min, 52°C for 30 sec and 68°C for
7 min; and a final extension at 68°C for 10 min. The
PCR products were extracted with one volume of Tris-
EDTA saturated (pH 4.5) phenol/chloroform/isoamyl al-
cohol (25:24:1) and precipitated with 1/10 volume 3 M
sodium acetate (pH 5.2) and 2.5 volumes of anhydrous
alcohol. The precipitated products were washed with
70% alcohol and digested with DpnI. After digestion, the
mutant plasmids were transformed into E. coli DH5α
cells and grown overnight at 37°C in the presence of
Table 2 Oligonucleotide primers used for site-directed mutagenesis and sequencing
Primer Positionc Sequenced Orientation
154Fa 3704-3740 5'-CCCTCGCACGCAGAGTGAACAACCGGCTGCCCACTTC-3' Sense
154Ra 3704-3740 5'-GAAGTGGGCAGCCGGTTGTTCACTCTGCGTGCGAGGG-3' Antisense
72GFa 2148-2181 5'-GTTTGACTGGACGCCGGGTTTGTCATTTGGACAC-3' Sense
72GRa 2148-2181 5'-GTGTCCAAATGACAAACCCGGCGTCCAGTCAAAC-3' Antisense
72NFa 2148-2181 5'-GTTTGACTGGACGCCGAATTTGTCATTTGGACAC-3' Sense
72NRa 2148-2181 5'-GTGTCCAAATGACAAATTCGGCGTCCAGTCAAAC-3' Antisense
107Fa 2253-2287 5'-GAGGAACGGGTGGGACATTGAGGTGACCGCTGTTG-3' Sense
107Ra 2253-2287 5'-CAACAGCGGTCACCTCAATGTCCCACCCGTTCCTC-3' Antisense
S1Fb 207-227 5'-AACAGCTATGACCATGATTAC-3' Sense
S1Rb 2677-2697 5'-GTTAGACACTTTCCCGTAGAC-3' Antisense
S2Rb 4000-4019 5'-GACATGTCCTCCTGCATCTG-3' Antisense
a Primers for the construction of mutant viruses.
b Primers for sequencing.
c The position of primers was determined according to the sequence of pAsi.
d The mutated codons are bolded and underlined.
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was digested with PstI and MluI and ligated into pAsi,
which had been digested with the same enzymes. The
other constructed plasmids, designated pNP-G, pNP-N
and pNP-I, were digested with NdeI and PstI and ligated
into pAsi, which had been digested with the same
enzymes. The final products were designated as
pAsiPM-N, pAsiNP-G, pAsiNP-N and pAsiNP-I and
verified by DNA sequencing.
Generation of rescued viruses from cDNA clones
The mutant-containing plasmids were linearized with
the restriction endonuclease EcoRV and used as tem-
plates for RNA synthesis with the RiboMAX™ Large
Scale RNA Production Systems-T7 kit (Promega, Madi-
son, WI, USA) according to the manufacturer0s instruc-
tions. After transcription, reaction mixtures were treated
with 1 U RQ1 DNase per μg RNA (Promega, Madison,
WI, USA). BHK-21 cells were Transfected with 5 μg of
in vitro transcribed RNA using the EffecteneW Transfec-
tion Reagent (Qiagen, Valencia, CA, USA). Supernatants
from the Transfected cells were used to infect fresh
BHK-21 cell monolayers. After a 48 h incubation at
37°C, viruses were harvested by three cycles of freeze-
thawing and were passages three more times on fresh
BHK-21 cell monolayers. Rescued viruses were examined
by an immunofluorescence assay using MAb 4B2 and
subjected to reverse transcriptase PCR (RT-PCR) for se-
quencing to confirm the introduced amino acid substitu-
tions and the absence of other changes.
Immunofluorescence analysis
BHK-21 cells were infected with the rescued viruses and
the parent virus at a MOI of 5.0 in 96-well plates, fixed
with ice-cold anhydrous ethanol 8 h post-infection for15 min at 4°C and air dried. Fifty micro liters of MAb
4B2 or MAb 1B4 (1:200 dilution in PBS) was added to
each well and incubated for 1 h at 37°C. After washing
with PBS, 50 μL of FITC-conjugated goat anti-mouse
IgG (1:200 dilution, Sigma, St. Louis, MO, USA) was
added to each well and incubated for 1 h at 37°C. Plates
were then washed three times with PBS and imaged with
an Olympus microscope connected to a Leica DFC490
digital color camera.RNA isolation, RT-PCR, and nucleotide sequence analysis
Genomic RNA from the rescued viruses was extracted
using TRIzol LS (Invitrogen, Carlsbad, CA, USA) according
to the manufacturer’s instructions. The RNA was reverse
transcribed into cDNA using Oligo-dT (15 T) as a primer,
and the PCR-amplified products were subjected to nucleo-
tide sequencing. The full-length genomic sequences of the
mutant viruses were analyzed to confirm the introduced
amino acid substitutions and the absence of other changes.Micro-neutralization assay
The micro-neutralization assay was performed according
to the Office International des Epizooties (OIE) manual
(http://www.oie.int/eng/normes/MMANUAL/2008/pdf/
2.01.05_FMD.pdf ). Briefly, two-fold serial dilutions of
heat-inactivated ascitic fluid were incubated with 50 μL
of 200 TCID50 units of FMDV for 1 h at 37°C in a 96-
well micro plate. Approximately 104 BHK-21 cells in
100 μL of media were seeded per well, and the cells
were incubated with virus and Ascites for five days
prior to being examined for a cytopathic effect. The
assay was independently performed three times, and
the neutralizing titer (NT50) was calculated using the
Kärber method.
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To monitor virus replication, BHK-21 cells were
infected with the mutant viruses at a multiplicity of in-
fection of 5 at 37°C, and the parent virus Asia1/YS/
CHA/05 was used as a control. After adsorption for
one hour, cells were rinsed with phosphate-buffered sa-
line (PBS, pH 7.4) to remove unabsorbed virus and
incubated in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 2% fetal calf serum.
Supernatants were harvested after 2, 4, 6, 8, 10, 12 and
14 h of incubation at 37°C and stored at -70°C. Virus
titers were determined and expressed as 50% tissue cul-
ture infectious doses (TCID50) using BHK-21 cells
grown in 96-well tissue culture plates according to
standard procedures. Five days after infection, the wells
exhibiting cytopathetic effect (CPE) were counted as
positive, and the virus titer (TCID50) was determined.
We calculated average values and standard deviations
for three independent experiments. In parallel, cell
monolayers infected as described before were collected
in TRIzol© (Invitrogen) and intracellular RNA was
obtained following manufacturer’s instructions; total
RNA in each sample was measured using a NanoVue
Spectrophotometer. cDNA was synthesized in the pres-
ence of AMV reverse transcriptase (TaKaRa) using 0.5
μg of Random Primers (TaKaRa). Finally, a real time-
PCR assay was performed in a Light CyclerW 480 Real-
Time PCR System (Roche Diagnostics) using a SYBRW
Premix Ex TaqTM (TaKaRa) and a standard amplifica-
tion profile with the primers D1 (AGACTCG
CATTGTCGATGTCTTG, forward primer) and D2
(CAAATCTTTGCCAATCAA TATCAG, reverse pri-
mer), to obtain a 150 bp fragment from the 3D region
of FMDV genome.
LD50 for virulence assay
To evaluate the pathogenicity of the rescued viruses, the
mutant viruses and the parent strain Asia1/YS/CHA/05
were inoculated into suckling BALB/c mice. Briefly, 3-
day-old of BALB/c suckling mice were divided into 24
groups (4 mice per group) and inoculated cervicodor-
sally with 200 μL of six serial tenfold dilutions of each
virus or PBS. Morbidity of the animals was examined
every six hours until seven days after inoculation, and
LD50 values were calculated by the Kärber method. The
experiments were repeated for three times and standard
deviations were calculated.
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